7Baggers
Quarterly
Annual
    Unit: USD2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2015-03-31 2014-03-31 2012-03-31 2011-09-30 2010-09-30 2009-09-30 
      
    		           
      cash flows from operating activities
    		           
      net income
    		37,371,000 15,427,000 9,842,000 9,720,000 8,927,000 5,070,000 4,785,000 1,876,000 -5,509,000 5,002,000 3,738,000 
      adjustments to reconcile net income to net cash from operating activities:
    		           
      depreciation and amortization
    		5,621,000 3,311,000 3,125,000 2,810,000 2,929,000 3,091,000 3,042,000 2,935,000 2,387,000 2,007,000 2,250,000 
      share-based compensation
    		1,373,000 3,229,000 1,139,000 1,125,000 1,191,000       
      equity method investment gain
    		           
      deferred income taxes, including change in valuation allowance
    		347,000 -648,000 101,000 145,000        
      change in fair value of contingent consideration
    		           
      other
    		24,000 -380,000 128,000  -62,000 120,000 -230,000  570,000  684,000 
      changes in operating assets and liabilities:
    		           
      receivables
    		-9,601,000 -4,348,000 -11,453,000 -5,088,000 -185,000 -194,000 -4,050,000 -7,984,000 -3,169,000   
      inventory
    		-13,696,000 4,924,000 -5,649,000 -2,561,000 -5,727,000 -3,213,000 4,042,000 -3,236,000 -1,908,000  3,415,000 
      prepaid expenses
    		657,000 -1,084,000 -2,339,000 -943,000 -1,005,000 -564,000 -942,000 -409,000 95,000   
      income taxes payable
    		5,437,000 5,237,000 3,100,000  1,048,000       
      accounts payable
    		4,638,000 509,000 1,635,000 -3,976,000 -2,238,000 819,000 -3,352,000 -1,880,000 -2,670,000   
      accrued expenses and other
    		-8,896,000 -8,385,000          
      federal and state excise taxes payable
    		-515,000           
      net cash from operating activities
    		22,230,000 16,990,000 542,000 -3,789,000 879,000 6,121,000 -642,000 -10,971,000 -13,948,000  3,250,000 
      capex
    		-10,642,000 -12,059,000 -5,645,000 -3,741,000 -6,978,000 -5,030,000 -2,182,000 -484,000 -384,000  0 
      free cash flows
    		11,588,000 4,931,000 -5,103,000 -7,530,000 -6,099,000 1,091,000 -2,824,000 -11,455,000 -14,332,000  3,250,000 
      cash flows from investing activities
    		           
      additions to property, plant, and equipment
    		-10,642,000 -12,059,000 -5,645,000 -3,741,000        
      net cash from investing activities
    		-12,033,000 -13,340,000 -8,189,000 -4,907,000 -7,040,000 -5,030,000 -2,182,000 10,351,000 -323,000  1,127,000 
      cash flows from financing activities
    		           
      payment of dividends and dividend equivalents
    		-2,661,000 -2,052,000 -2,060,000 -1,714,000 -1,375,000       
      repurchase of common stock
    		           
      loan fees paid related to borrowings
    		  -1,148,000         
      proceeds from long-term debt
    		           
      principal payments on long-term debt
    		-807,000  -100,000 -95,000 -93,000 -398,000 -384,000 -413,000 -474,000   
      net cash from financing activities
    		-4,182,000 -2,726,000 46,997,000 3,671,000 4,200,000 -341,000 -33,000 237,000 7,654,000 1,343,000  
      effect of exchange rate changes on cash and cash equivalents
    		           
      increase in cash and cash equivalents
    		5,727,000 924,000 39,350,000   750,000  -383,000    
      cash and cash equivalents, beginning of period
    		21,568,000 21,662,000 3,309,000 5,025,000 3,084,000       
      cash and cash equivalents, end of period
    		27,295,000 22,586,000 42,659,000  1,123,000 6,391,000   986,000 157,000  
      impairment of long-lived assets and other
    		           
      goodwill impairment
    		           
      changes in operating assets and liabilities, net of effects of acquisitions:
    		           
      purchase of business, net of cash acquired
    		           
      contributions to equity method investments
    		           
      cash and cash equivalents, beginning of year
    		     5,641,000 2,857,000 383,000 7,603,000 6,369,000 178,000 
      cash and cash equivalents, end of year
    		           
      changes in operating assets and liabilities, net of effects of acquisition:
    		           
      equity method investment loss
    		           
      gain on insurance recoveries
    		           
      proceeds from property insurance recoveries
    		           
      purchase of treasury stock
    		-714,000 -674,000 -4,395,000    -104,000  -84,000   
      loan fees incurred with borrowings
    		     -291,000      
      proceeds from credit agreement - revolver
    		  54,700,000 11,025,000        
      payments on credit agreement - revolver
    		           
      proceeds from convertible senior notes
    		           
      payment on assumed debt as part of the merger
    		           
      contributions to equity method investment
    		-1,028,000           
      proceeds from sale of property and other
    		           
      refundable income taxes
    		   -1,649,000   208,000 120,000    
      effect of exchange rate changes on cash
    		-288,000           
      gain on equity method investment
    		-394,000           
      gain on sale of assets
    		  -9,000 -138,000      289,000  
      federal and state liquor taxes payable
    		           
      proceeds from sale of property
    		  366,000         
      net income attributable to noncontrolling interest
    		           
      unrealized gain on foreign currency
    		           
      loss on sale of assets
    		       48,000    
      deferred credits
    		 -802,000 -81,000 -83,000        
      acquisition of business
    		  -2,750,000         
      accrued expenses
    		  1,003,000 -3,140,000 -4,009,000 -1,248,000 -1,951,000 904,000 -389,000  387,000 
      deferred compensation plan investments
    		   -1,166,000        
      gain on sale of equity method investment
    		           
      distributions received from equity method investee
    		           
      accounts payable to affiliate
    		     685,000 1,360,000 -1,380,000 -1,546,000   
      divestiture of equity method investment
    		           
      purchase of treasury stock for tax withholding on equity-based compensation
    		   -5,467,000        
      accrued retirement health, and life insurance benefits
    		   -11,000        
      proceeds on long-term debt
    		           
      decrease in cash and cash equivalents
    		   -5,025,000 -1,961,000  -2,857,000  -6,617,000   
      gain on property insurance recoveries
    		           
      equity method investment (earnings) loss
    		      -3,334,000     
      accrued retirement, health, and life insurance benefits
    		           
      acquisition of george remus®
    		           
      increase in cash
    		           
      cash, beginning of year
    		           
      cash, end of year
    		           
      balance, december 31, 2015
    		           
      comprehensive income:
    		           
      other comprehensive income
    		           
      dividends and dividend equivalents, net of estimated forfeitures
    		           
      stock shares awarded, forfeited or vested
    		           
      stock shares repurchased
    		           
      balance, december 31, 2016
    		           
      balance, december 31, 2017
    		           
      balance, december 31, 2018
    		           
      deferred income taxes
    		    279,000 2,027,000      
      income taxes payable/refundable
    		           
      deferred credit
    		    -217,000 -160,000 -155,000 -150,000 -152,000   
      accrued retirement health and life insurance benefits
    		    -114,000       
      additions to plant, property and equipment
    		    -6,978,000       
      return of equity method investment
    		           
      purchase of treasury stock for tax withholding on share-based compensation
    		    -2,073,000       
      proceeds from credit agreement
    		    7,741,000       
      payments on credit agreement
    		           
      equity method investment earnings
    		     -1,352,000      
      distribution received from equity method investee
    		           
      payment of dividends
    		           
      principal payments on credit agreement
    		           
      balance, december 31, 2014
    		           
      excess tax benefits
    		           
      proceeds from credit facility
    		           
      payments on credit facility
    		           
      inventory, net of assets acquired in acquisition
    		           
      additions to property and equipment
    		     -5,030,000 -2,182,000 -484,000 -384,000   
      divestiture of dmi
    		           
      balance, december 31, 2013
    		           
      other comprehensive loss
    		           
      stock shares repurchased for payment of taxes
    		           
      balance, december 2014
    		           
      balance, december 2015
    		           
      balance, december 2016
    		           
      gain on sale of bioplastics manufacturing business
    		           
      share based compensation
    		     205,000 149,000 353,000 176,000   
      restricted cash
    		       1,454,000 -7,140,000 971,000 200,000 
      accrued retirement health and life insurance benefits, pension obligations, and other noncurrent liabilities
    		           
      proceeds from sale of bioplastics manufacturing business
    		           
      principal payments on credit facility
    		           
      balance, december 31, 2012
    		           
      comprehensive loss:
    		           
      dividends paid
    		           
      accrued retirement health and life insurance benefits and other accrued retiree benefits
    		           
      loss on property insurance recoveries
    		           
      accrued retirement health and life insurance benefits and other noncurrent liabilities
    		     -127,000 -214,000 -261,000 -85,000   
      proceeds from revolving credit facility
    		     1,086,000 14,776,000 43,756,000 104,982,000   
      payments on revolving credit facility
    		     -738,000 -14,321,000     
      accrued income taxes
    		     962,000      
      gains on property insurance recoveries
    		           
      release of valuation allowance for deferred tax assets
    		           
      gain on sale of joint venture interest
    		       -4,055,000    
      loss/(gain) on sale of assets
    		           
      equity in loss
    		           
      change in derivatives
    		       1,131,000    
      investments in/ advances to equity method investments
    		           
      proceeds from sale of interest in icp
    		           
      proceeds from disposition of property and equipment
    		           
      principal payments on revolving credit facility
    		       -43,106,000 -96,770,000   
      equity in (earnings) loss of joint ventures
    		        2,830,000   
      net cash from (used by) operating activities
    		           
      proceeds from sale of joint venture interest
    		       9,103,000    
      proceeds from the disposition of property and equipment
    		       2,232,000 61,000   
      investment in and advances to unconsolidated subsidiaries
    		       -500,000    
      net cash from (used by) investing activities
    		           
      net cash from (used by) financing activities
    		           
      bargain purchase gain, net of tax
    		           
      loss on impairment of assets
    		           
      changes in operating assets and liabilities, net of acquisition:
    		           
      acquisition of ldi’s distillery business
    		           
      proceeds from stock plans
    		           
      exercise of stock options
    		           
      proceeds from issuance of long-term debt
    		           
      equity in earnings of joint ventures
    		       -437,000    
      loss on joint venture formation
    		           
      equity in loss of joint ventures
    		           
      gains previously deferred in other comprehensive income
    		           
      investments in/ advances to joint ventures
    		           
      proceeds from sale of interest in joint venture
    		           
      tax effect of restricted stock awards
    		           
      change in derivative valuation
    		        2,562,000   
      accrued retirement health and life insurance benefits and other non-current liabilities
    		           
      investment in/advances to joint ventures
    		           
      proceeds from sale of interest in joint ventures
    		           
      income taxes payable/receivable
    		          42,000 
      accrued retirement health and life insurance benefits and other non current liabilities
    		           
      proceeds from long-term debt and capital leases
    		          2,032,000 
      proceeds from line of credit
    		         62,335,000 49,273,000 
      principal payments on line of credit
    		           
      changes in working capital items:
    		           
      investments in/ advances to joint venture
    		           
      adjustments to reconcile net income to net cash used by operating activities:
    		           
      joint venture operations loss
    		           
      accrued natural gas derivative
    		           
      income taxes payable / refundable
    		           
      accrual for retirement benefits and other non-current liabilities
    		           
      tax effect of restricted stock awarded
    		           
      proceeds from revolving line of credit
    		           
      principal payments on revolving line of credit
    		           
      joint venture operations
    		           
      receivables/receivables from affiliate
    		           
      accounts payable/accounts payable to affiliate
    		           
      accrued retirement benefits and other non-current liabilities
    		           
      equity in loss of joint venture
    		          48,000 
      accounts receivable
    		           
      other non-current liabilities
    		           
      proceeds from sale of assets
    		          1,127,000 
      principal payments on long-term debt and capital leases
    		           
      loss on write-off of assets
    		           
      investments in and advances to joint venture
    		           
      proceeds from disposition of equipment
    		           
      impairment of long lived assets
    		           
      accrual for natural gas derivative
    		           
      accounts payable and accrued expenses
    		           
      write-off of assets
    		           
      deferred revenue
    		           
      segregated cash and investments
    		           
      inventories
    		           
      net proceeds from line of credit
    		           
      items not requiring (providing) cash:
    		           
      changes in:
    		           
      stock repurchased
    		           
      depreciation
    		           
      gain on insurance recovery
    		           
      items not requiring cash
    		           
      gain on sale/conversion of property and equipment
    		           
      insurance receivable
    		           
      deferred income
    		           
      income taxes receivable
    		           
      proceeds from sale/conversion of property and equipment
    		           
      payments on long-term debt
    		           
      stock compensation
    		           
      income taxes (receivable) payable
    		           
      exercise and vesting of stock options
    		           
      net proceeds on line of credit
    		           
      dividends payable
    		           
      sale of treasury stock
    		           
      operating activities
    		           
      income taxes receivable/payable
    		           
      investing activities
    		           
      insurance proceeds from property damage
    		           
      financing activities
    		           
      sales of treasury stock
    		           
      borrowings on line of credit
    		           
      changes in
    		           
      proceeds from sale/conversion of equipment
    		           
      net payments on long-term debt
    		           
      net purchases of investments
    		           
      items not requiring (providing) cash
    		           
      net proceeds from disposition of investments
    		           
      financing activities;
    		           
      net proceeds from issuance of long-term debt
    		           
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.